Supplementary Table 2.docx (26.84 kB)

Supplementary Table 2. Nivolumab in gastric/gastroesophageal junction cancer: real-world data from UK Early Access to Medicines Scheme

dataset

posted on 2021-06-08, 08:34 authored by Mira Soni, Christopher Kiff, Robert Carroll, Dara Stein, Delphine Saragoussi, Ayman Nassar, Nick Maisey, David Tyas

Supplementary Table 2. Disease Characteristics and Medical History at Baseline for Patients Enrolled in EAMS Who Consented to Observational Research

Funding

Bristol-Myers Squibb

History

Usage metrics

Future Oncology

Keywords

ATTRACTION-2 CheckMate-032 Early Access to Medicines Scheme EQ-5D Gastric/gastrointestinal adenocarcinoma Health-related Quality of Life Medical records Nivolumab Real-world Solid Tumours

Licence

CC BY-NC-ND 4.0